Global Viral-Vectored Vaccines Sales Market Report Forecast 2017-2021

March 2017 | 120 pages | ID: G45D440D660EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

• United States
• China
• Europe
• Japan

The Major players reported in the market include:
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)

• Indian Immunologicals Ltd (India)

Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 VIRAL-VECTORED VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Viral-Vectored Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Viral-Vectored Vaccines Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Viral-Vectored Vaccines (2012-2021)
  1.5.1 Global Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Global Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON VIRAL-VECTORED VACCINES INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 VIRAL-VECTORED VACCINES MANUFACTURING COST ANALYSIS

3.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Viral-Vectored Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL VIRAL-VECTORED VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Viral-Vectored Vaccines Market Competition by Manufacturers
  5.1.1 Global Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Viral-Vectored Vaccines Revenue and Share by Manufacturers (2012-2017)
5.2 Global Viral-Vectored Vaccines (Volume and Value) by Type
  5.5.1 Global Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)
  5.5.2 Global Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global Viral-Vectored Vaccines (Volume and Value) by Regions
  5.3.1 Global Viral-Vectored Vaccines Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Viral-Vectored Vaccines Revenue and Market Share by Regions (2012-2017)
5.4 Global Viral-Vectored Vaccines (Volume) by Application

6 UNITED STATES VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 United States Viral-Vectored Vaccines Sales and Value (2012-2017)
  6.1.1 United States Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 United States Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 United States Viral-Vectored Vaccines Sales Price Trend (2012-2017)
6.2 United States Viral-Vectored Vaccines Sales and Market Share by Manufacturers
6.3 United States Viral-Vectored Vaccines Sales and Market Share by Type
6.4 United States Viral-Vectored Vaccines Sales and Market Share by Application

7 CHINA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 China Viral-Vectored Vaccines Sales and Value (2012-2017)
  7.1.1 China Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 China Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 China Viral-Vectored Vaccines Sales Price Trend (2012-2017)
7.2 China Viral-Vectored Vaccines Sales and Market Share by Manufacturers
7.3 China Viral-Vectored Vaccines Sales and Market Share by Type
7.4 China Viral-Vectored Vaccines Sales and Market Share by Application

8 EUROPE VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Viral-Vectored Vaccines Sales and Value (2012-2017)
  8.1.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Viral-Vectored Vaccines Sales Price Trend (2012-2017)
8.2 Europe Viral-Vectored Vaccines Sales and Market Share by Manufacturers
8.3 Europe Viral-Vectored Vaccines Sales and Market Share by Type
8.4 Europe Viral-Vectored Vaccines Sales and Market Share by Application

9 JAPAN VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Viral-Vectored Vaccines Sales and Value (2012-2017)
  9.1.1 Japan Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Japan Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Viral-Vectored Vaccines Sales Price Trend (2012-2017)
9.2 Japan Viral-Vectored Vaccines Sales and Market Share by Manufacturers
9.3 Japan Viral-Vectored Vaccines Sales and Market Share by Type
9.4 Japan Viral-Vectored Vaccines Sales and Market Share by Application

10 GLOBAL VIRAL-VECTORED VACCINES MANUFACTURERS ANALYSIS

10.1 Bayer HealthCare AG (Germany)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Biogenesis-Bago (Argentina)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Boehringer Ingelheim GmbH (Germany)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Ceva Sante Animale (France)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Heska Corporation (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Indian Immunologicals Ltd (India)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Lohmann Animal Health (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Merck Animal Health (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Merial Ltd. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL VIRAL-VECTORED VACCINES MARKET FORECAST (2017-2021)

13.1 Global Viral-Vectored Vaccines Sales, Revenue Forecast (2017-2021)
13.2 Global Viral-Vectored Vaccines Sales Forecast by Regions (2017-2021)
13.3 Global Viral-Vectored Vaccines Sales Forecast by Type (2017-2021)
13.4 Global Viral-Vectored Vaccines Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Global Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Table Applications of Viral-Vectored Vaccines
Figure Global Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure United States Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure China Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Japan Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Global Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)
Figure Global Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Table Global Viral-Vectored Vaccines Sales of Key Manufacturers (2012-2017)
Table Global Viral-Vectored Vaccines Sales Share by Manufacturers (2012-2017)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table Global Viral-Vectored Vaccines Revenue by Manufacturers (2012-2017)
Table Global Viral-Vectored Vaccines Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 Global Viral-Vectored Vaccines Revenue Share by Manufacturers
Table Global Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)
Table Global Viral-Vectored Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Type (2012-2017)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Type (2012-2017)
Table Global Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)
Table Global Viral-Vectored Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2012-2017)
Figure Global Viral-Vectored Vaccines Revenue Growth Rate by Type (2012-2017)
Table Global Viral-Vectored Vaccines Sales and Market Share by Regions (2012-2017)
Table Global Viral-Vectored Vaccines Sales Share by Regions (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Regions (2012-2017)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Regions (2012-2017)
Table Global Viral-Vectored Vaccines Revenue and Market Share by Regions (2012-2017)
Table Global Viral-Vectored Vaccines Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Viral-Vectored Vaccines by Regions (2012-2017)
Figure Global Viral-Vectored Vaccines Revenue Growth Rate by Regions (2012-2017)
Table Global Viral-Vectored Vaccines Sales and Market Share by Application (2012-2017)
Table Global Viral-Vectored Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Application (2012-2017)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure United States Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure United States Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table United States Viral-Vectored Vaccines Sales by Manufacturers (2012-2017)
Table United States Viral-Vectored Vaccines Market Share by Manufacturers (2012-2017)
Table United States Viral-Vectored Vaccines Sales by Type (2012-2017)
Table United States Viral-Vectored Vaccines Market Share by Type (2012-2017)
Table United States Viral-Vectored Vaccines Sales by Application (2012-2017)
Table United States Viral-Vectored Vaccines Market Share by Application (2012-2017)
Figure China Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure China Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure China Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table China Viral-Vectored Vaccines Sales by Manufacturers (2012-2017)
Table China Viral-Vectored Vaccines Market Share by Manufacturers (2012-2017)
Table China Viral-Vectored Vaccines Sales by Type (2012-2017)
Table China Viral-Vectored Vaccines Market Share by Type (2012-2017)
Table China Viral-Vectored Vaccines Sales by Application (2012-2017)
Table China Viral-Vectored Vaccines Market Share by Application (2012-2017)
Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Europe Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Europe Viral-Vectored Vaccines Sales by Manufacturers (2012-2017)
Table Europe Viral-Vectored Vaccines Market Share by Manufacturers (2012-2017)
Table Europe Viral-Vectored Vaccines Sales by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Market Share by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Sales by Application (2012-2017)
Table Europe Viral-Vectored Vaccines Market Share by Application (2012-2017)
Figure Japan Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Japan Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Japan Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Japan Viral-Vectored Vaccines Sales by Manufacturers (2012-2017)
Table Japan Viral-Vectored Vaccines Market Share by Manufacturers (2012-2017)
Table Japan Viral-Vectored Vaccines Sales by Type (2012-2017)
Table Japan Viral-Vectored Vaccines Market Share by Type (2012-2017)
Table Japan Viral-Vectored Vaccines Sales by Application (2012-2017)
Table Japan Viral-Vectored Vaccines Market Share by Application (2012-2017)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ceva Sante Animale (France) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Heska Corporation (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lohmann Animal Health (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Animal Health (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merial Ltd. (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure Global Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Global Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Regions (2017-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Type (2017-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Application (2017-2021)